Ha H et al. |
Lipid rafts are important for the association of RANK and TRAF6. |
2003 |
Exp. Mol. Med. |
pmid:14508068
|
Brändström H et al. |
Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women. |
2004 |
Calcif. Tissue Int. |
pmid:14508625
|
Seidlova-Wuttke D et al. |
Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. |
2003 |
Eur. J. Endocrinol. |
pmid:14514351
|
Sattler AM et al. |
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. |
2004 |
Calcif. Tissue Int. |
pmid:14523602
|
Bergh JJ et al. |
Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. |
2004 |
Endocrinology |
pmid:14525906
|
Malyszko J et al. |
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. |
2003 |
Transplant. Proc. |
pmid:14529897
|
Ren W et al. |
Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles. |
2003 |
Biomaterials |
pmid:14530078
|
Wiethe C et al. |
Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. |
2003 |
J. Immunol. |
pmid:14530334
|
Wagner EF and Matsuo K |
Signalling in osteoclasts and the role of Fos/AP1 proteins. |
2003 |
Ann. Rheum. Dis. |
pmid:14532157
|
Ueland T et al. |
Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over. |
2003 |
Bone |
pmid:14555269
|
Nagata N et al. |
Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. |
2003 |
Bone |
pmid:14555278
|
Smith BB et al. |
A toxicity profile of osteoprotegerin in the cynomolgus monkey. |
2003 Sep-Oct |
Int. J. Toxicol. |
pmid:14555415
|
Cho TJ et al. |
Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors. |
2003 |
Arthritis Rheum. |
pmid:14558090
|
von Tirpitz C et al. |
Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. |
2003 |
Eur J Gastroenterol Hepatol |
pmid:14560148
|
Fan X et al. |
Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. |
2004 |
Endocrinology |
pmid:14563699
|
Barillé-Nion S and Bataille R |
New insights in myeloma-induced osteolysis. |
2003 |
Leuk. Lymphoma |
pmid:14565645
|
Novack DV |
TSH, the bone suppressing hormone. |
2003 |
Cell |
pmid:14567908
|
Abe E et al. |
TSH is a negative regulator of skeletal remodeling. |
2003 |
Cell |
pmid:14567913
|
Zhao ZM et al. |
[The preliminary study on in vitro differentiation of human umbilical cord blood cells into neural cells]. |
2003 |
Zhonghua Xue Ye Xue Za Zhi |
pmid:14575594
|
Boyan BD et al. |
Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. |
2003 |
Eur Cell Mater |
pmid:14577052
|
Grimaud E et al. |
Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. |
2003 |
Am. J. Pathol. |
pmid:14578201
|
Price PA et al. |
Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. |
2004 |
J. Biol. Chem. |
pmid:14578360
|
Coen G et al. |
Serum leptin in dialysis renal osteodystrophy. |
2003 |
Am. J. Kidney Dis. |
pmid:14582047
|
Chagraoui H et al. |
Expression of osteoprotegerin mRNA and protein in murine megakaryocytes. |
2003 |
Exp. Hematol. |
pmid:14585373
|
Takayanagi H |
[Crosstalk between the immune and skeletal system]. |
2003 |
Ryumachi |
pmid:14598653
|
Naylor KE et al. |
Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:14602774
|
Heim M et al. |
The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. |
2004 |
Endocrinology |
pmid:14605006
|
Crotti TN et al. |
Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. |
2004 |
Biomaterials |
pmid:14607494
|
Hayashi S et al. |
Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. |
2003 |
J. Immunol. |
pmid:14607912
|
Padigel UM et al. |
TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice. |
2003 |
J. Immunol. |
pmid:14607948
|
Hortobagyi GN |
Novel approaches to the management of bone metastases. |
2003 |
Semin. Oncol. |
pmid:14613037
|
Voskaridou E et al. |
Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. |
2003 |
Br. J. Haematol. |
pmid:14616979
|
Uemura H et al. |
Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover. |
2003 |
Bone |
pmid:14623063
|
Terpos E et al. |
New insights into the pathophysiology and management of bone disease in multiple myeloma. |
2003 |
Br. J. Haematol. |
pmid:14632767
|
Zhang J et al. |
Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. |
2003 |
Cancer Res. |
pmid:14633717
|
Chan BY et al. |
Effect of anticoagulants and storage temperature on the stability of receptor activator for nuclear factor-kappa B ligand and osteoprotegerin in plasma and serum. |
2003 |
Clin. Chem. |
pmid:14633883
|
Jung K et al. |
Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer. |
2003 |
J. Urol. |
pmid:14634401
|
Su X et al. |
[The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells]. |
2003 |
Zhonghua Nei Ke Za Zhi |
pmid:14636471
|
Mandelin J et al. |
Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. |
2003 |
J Bone Joint Surg Br |
pmid:14653607
|
Pennisi P et al. |
Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. |
2004 |
Osteoporos Int |
pmid:14661073
|
Miyahira Y et al. |
Cutting edge: a potent adjuvant effect of ligand to receptor activator of NF-kappa B gene for inducing antigen-specific CD8+ T cell response by DNA and viral vector vaccination. |
2003 |
J. Immunol. |
pmid:14662831
|
Stilgren LS et al. |
Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. |
2003 |
Calcif. Tissue Int. |
pmid:14667132
|
Okada T et al. |
Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. |
2003 |
Clin. Exp. Metastasis |
pmid:14669795
|
Gannagé-Yared MH et al. |
Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. |
2003 |
J. Endocrinol. Invest. |
pmid:14669830
|
Ashcroft AJ et al. |
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. |
2003 |
Immunity |
pmid:14670302
|
Chong B et al. |
Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. |
2003 |
J. Bone Miner. Res. |
pmid:14672344
|
Nielsen KL et al. |
Biglycan deficiency interferes with ovariectomy-induced bone loss. |
2003 |
J. Bone Miner. Res. |
pmid:14672350
|
Kumamoto H and Ooya K |
Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas. |
2004 |
J. Oral Pathol. Med. |
pmid:14675140
|
Crotti TN et al. |
Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis. |
2003 |
J. Rheumatol. |
pmid:14677171
|
Buzi F et al. |
Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis. |
2004 |
Clin. Endocrinol. (Oxf) |
pmid:14678293
|
Cheng X et al. |
Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo. |
2004 |
J. Biol. Chem. |
pmid:14679212
|
Liu JZ et al. |
[Expression of human osteoprotegerin gene in E. Coli and bioactivity analysis of expression product]. |
2003 |
Zhonghua Wai Ke Za Zhi |
pmid:14680558
|
Yamada Y et al. |
Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. |
2003 |
Mol. Genet. Metab. |
pmid:14680982
|
Ogasawara T et al. |
In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue. |
2004 |
J. Periodont. Res. |
pmid:14687227
|
Brubaker KD et al. |
Bone morphogenetic protein signaling in prostate cancer cell lines. |
2004 |
J. Cell. Biochem. |
pmid:14689587
|
Gehrke T et al. |
Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. |
2003 |
Scand. J. Rheumatol. |
pmid:14690142
|
Zhang D et al. |
The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3. |
2004 |
Arch. Oral Biol. |
pmid:14693199
|
Stolina M et al. |
Regulatory effects of osteoprotegerin on cellular and humoral immune responses. |
2003 |
Clin. Immunol. |
pmid:14697750
|
Blair HC and Athanasou NA |
Recent advances in osteoclast biology and pathological bone resorption. |
2004 |
Histol. Histopathol. |
pmid:14702187
|
Vegni FE et al. |
Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis. |
2004 |
N. Engl. J. Med. |
pmid:14711922
|
Crisafulli A et al. |
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. |
2004 |
J. Clin. Endocrinol. Metab. |
pmid:14715848
|
Onyia JE et al. |
Novel and selective small molecule stimulators of osteoprotegerin expression inhibit bone resorption. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:14718597
|
Skoumal M et al. |
Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis. |
2004 |
Ann. Rheum. Dis. |
pmid:14722219
|
Hofbauer LC et al. |
Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women. |
2004 |
Clin. Endocrinol. (Oxf) |
pmid:14725683
|
Yoneda T et al. |
Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. |
2004 |
Endocrinology |
pmid:14726437
|
Wittrant Y et al. |
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. |
2004 |
Exp. Cell Res. |
pmid:14729467
|
Hruska KA et al. |
Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. |
2004 |
Semin. Nephrol. |
pmid:14730507
|
Zwerina J et al. |
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. |
2004 |
Arthritis Rheum. |
pmid:14730626
|
Mallat Z and Tedgui A |
Unbalanced RANKL/RANK pathway in aortic valve sclerosis. |
2004 |
J. Mol. Cell. Cardiol. |
pmid:14734042
|
Kaden JJ et al. |
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. |
2004 |
J. Mol. Cell. Cardiol. |
pmid:14734048
|
Guillonneau C et al. |
The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. |
2004 |
J. Immunol. |
pmid:14734743
|
Sudhoff H et al. |
[Expression of osteoclast stimulating and differentiating factors in a murine model of localized inflammatory bone resorption]. |
2004 |
Laryngorhinootologie |
pmid:14740300
|
Findlay DM et al. |
The proliferation and phenotypic expression of human osteoblasts on tantalum metal. |
2004 |
Biomaterials |
pmid:14741587
|
Theoleyre S et al. |
Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. |
2004 |
Biochim. Biophys. Acta |
pmid:14741739
|
Redlich K et al. |
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. |
2004 |
Am. J. Pathol. |
pmid:14742260
|
Mogi M et al. |
Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. |
2004 |
J. Dent. Res. |
pmid:14742657
|
Takayanagi H |
[Signaling mechanism in the regulation of osteoclast differentiation by the immune system]. |
2003 |
Seikagaku |
pmid:14748148
|
Itonaga I et al. |
Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. |
2004 |
Bone |
pmid:14751563
|
Pan B et al. |
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). |
2004 |
J. Bone Miner. Res. |
pmid:14753746
|
Valverde P et al. |
Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. |
2004 |
J. Bone Miner. Res. |
pmid:14753747
|
Amizuka N et al. |
Defective bone remodelling in osteoprotegerin-deficient mice. |
2003 |
J Electron Microsc (Tokyo) |
pmid:14756238
|
Kawana F and Sasaki T |
Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice. |
2003 |
J Electron Microsc (Tokyo) |
pmid:14756239
|
Suda K et al. |
Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. |
2004 |
J. Immunol. |
pmid:14764723
|
Saidenberg-Kermanac'h N et al. |
Role for osteoprotegerin in rheumatoid inflammation. |
2004 |
Joint Bone Spine |
pmid:14769514
|
Durán A et al. |
The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. |
2004 |
Dev. Cell |
pmid:14960283
|
Wang FS et al. |
Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats. |
2004 |
Endocrinology |
pmid:14962990
|
Harashima SI et al. |
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand expression in fibroblast-like synoviocytes from rheumatoid arthritis and osteoarthritis patients. |
2004 |
Rheumatology (Oxford) |
pmid:14963213
|
Huang JC et al. |
PTH differentially regulates expression of RANKL and OPG. |
2004 |
J. Bone Miner. Res. |
pmid:14969393
|
He J et al. |
Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. |
2004 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:14970783
|
Ohazama A et al. |
Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis. |
2004 |
J. Dent. Res. |
pmid:14981127
|
Gruber HE and Rude RK |
Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse. |
2003 |
Biotech Histochem |
pmid:14989640
|
Kubota A et al. |
Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts. |
2004 |
J. Rheumatol. |
pmid:14994384
|
Kötter I and Stübiger N |
Therapeutic implications for interferon-alpha in arthritis. |
2004 |
J. Rheumatol. |
pmid:14994421
|
Schett G et al. |
Soluble RANKL and risk of nontraumatic fracture. |
2004 |
JAMA |
pmid:14996780
|
Tsuji K et al. |
Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. |
2004 |
J. Bone Miner. Metab. |
pmid:14999519
|
Jørgensen HL et al. |
Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios. |
2004 |
J. Bone Miner. Metab. |
pmid:14999524
|
Wagner TU et al. |
The teleost fish medaka (Oryzias latipes) as genetic model to study gravity dependent bone homeostasis in vivo. |
2003 |
Adv Space Res |
pmid:15000082
|
Baek KH et al. |
Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. |
2004 |
J. Clin. Endocrinol. Metab. |
pmid:15001618
|
Brage M et al. |
Osteoclastogenesis is decreased by cysteine proteinase inhibitors. |
2004 |
Bone |
pmid:15003789
|
Fukunaga J et al. |
Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506. |
2004 |
Bone |
pmid:15003790
|